BACKGROUND
Family screening is recommended in dilated cardiomyopathy (DCM), but risk stratification of relatives of probands without pathogenic or likely pathogenic variants (gene-elusive) remains uncertain.
OBJECTIVES
This study sought to define the incidence, prognosis, and predictors of disease development in firs...
A. Paldino, E. Del Mestre, I. Gandin et al.· JACC. Heart failure· 0 citations
Late Gadolinium Enhancement (LGE) on cardiac magnetic resonance is a key marker of myocardial scar, but its limited accessibility motivates routine ECG-based screening. We evaluated whether $\beta$-variational autoencoder (VAE)-derived ECG representations can discriminate LGE+ from LGE- cardiomyopathic patients in a lo...
Shayan Sharifi, R. Treu, I. Gandin et al.· 0 citations
PDrV carriers have a higher risk of severe cardiac events, even without a clinical overt disease phenotype at baseline evaluation, and PDrV in arrhythmic genes significantly influence SCD/MVA risk, regardless of phenotypic diagnosis of DCM.
I. Gandin, A. Vergani, M. Massi et al.· JACC: Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.